Icon rides latest outsourcing wave with launch of medical device and diagnostics research group
Global CRO Icon has packaged a combination of its services to create a medical device and diagnostics research group designed to provide global clinical trials, health economics and pricing and market access tools.
The Medical Device & Diagnostic Research Group incorporates Aptiv Solutions, a CRO specializing in medical device and adaptive trials, which Dublin-based Icon acquired last May.
“When we talk to large medical device companies, they really want to work with a large CRO that has a device service line and staff who understand how the FDA deals with device evaluations and approvals,” said Vicki Anastasi, Icon’s vice president of medical technology, who will lead the new group.
Within weeks after closing the Aptiv acquisition, Icon executives saw how different the device and diagnostic markets were from the traditional pharmaceutical and biotech models, Anastasi explained. That distinction, she said, was the genesis for forming a separate organization tailored to devices and diagnostics.
For the complete story, see Monday’s CWWeekly.